Healios K.K. to Highlight Its Novel Approach in Regenerative Medicine at the Upcoming 38th Annual J.P. Morgan Healthcare Conference and Biotech Showcase in San Francisco, CA

[In The News]

TOKYO, Jan. 9, 2020 /PRNewswire/ -- Healios K.K. ("the Company"); (TSE: 4593), Japan's leading clinical stage biotechnology company harnessing the potential of stem cells for regenerative therapies announces that its Chairman and Chief Executive Officer, Hardy TS Kagimoto, MD, will...

View the full article